Zina Yudina
is Founder and CEO of Babylat AG, a Swiss medtech company developing innovative solutions for individualized neonatal nutrition. Her work focuses on advancing human milk–based fortification technologies to improve outcomes for preterm infants. She leads international collaborations across clinical, engineering, and regulatory domains to bring the Babylat Enricher and related technologies to clinical practice.
Role in the project: Project lead for Babylat AG, responsible for development and validation of the Babylat Enricher, coordination of human milk analysis (HMA) development together with PREMS, and overall project execution, including regulatory and commercialization strategy.